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ABSTRACT 24 
Marfan syndrome (MFS) is a connective tissue disorder that is often associated with 25 
fibrillin-1 (Fbn1) gene mutation and characterized by cardiovascular alterations, 26 
predominantly ascending aortic aneurysms. Although neurovascular complications are 27 
uncommon in MFS, the improvement in Marfan patients’ life expectancy is revealing 28 
other secondary alterations, potentially including neurovascular disorders. However, 29 
little is known about small vessel pathophysiology in MFS. MFS is associated with 30 
hyperactivated transforming growth factor (TGF)-β signaling, which, among numerous 31 
other downstream effectors, induces the Nox4 isoform of NADPH oxidase, a strong 32 
enzymatic source of H2O2. We hypothesized that MFS induces middle cerebral artery 33 
(MCA) alterations, and that Nox4 contributes to them. MCA properties from 3-, 6- or 9-34 
month-old Marfan (Fbn1C1039G/+) mice were compared with those from age/sex-matched 35 
wild-type littermates. At 6 months, Marfan compared with wild-type mice developed 36 
higher MCA wall/lumen (wild-type: 0.081 ± 0.004; Marfan: 0.093 ± 0.002; 60 mmHg; P 37 
< 0.05), coupled with increased reactive oxygen species production, TGF-β and Nox4 38 
expression. However, wall stiffness and myogenic autoregulation did not change. To 39 
investigate the influence of Nox4 on cerebrovascular properties, we generated Marfan 40 
mice with Nox4 deficiency (Nox4-/-). Strikingly, Nox4 deletion in Marfan mice 41 
aggravated MCA wall thickening (cross-sectional area; Marfan: 6660 ± 363 μm2; 42 
Marfan Nox4-/-: 8795 ± 824 μm2; 60 mmHg; P < 0.05), accompanied by decreased 43 
TGF-β expression, and increased collagen deposition and Nox1 expression. These 44 
findings provide the first evidence that Nox4 mitigates cerebral artery structural 45 
changes in a murine model of MFS.  46 
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NEW & NOTEWORTHY 50 
This is the first study to characterize the cerebral artery properties in an animal model 51 
of Marfan syndrome. Importantly, we reveal a role for Nox4 in attenuating brain 52 
vascular structural changes in Marfan syndrome, which may confer protection against 53 
the development of neurovascular disorders during Marfan syndrome progression.  54 
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 70 
INTRODUCTION 71 
Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder with 72 
multiple clinical manifestations, including cardiovascular alterations (5, 26). Mutations 73 
of the gene encoding fibrillin-1 (Fbn1) are the underlying cause (17). Fibrillin-1 is a 74 
scaffolding protein that is crucial for elastin deposition and the formation of elastic 75 
fibers and laminae (41). Aortic aneurysm leading to aortic dissection and rupture is the 76 
event that contributes to premature mortality (5). Neurovascular disorders are 77 
uncommon in Marfan patients. In a retrospective hospital-based study, in which 78 
patients affected with MFS were seen between 1989 and 1997 (49), no major 79 
association of MFS with neurovascular complications has been clearly reported. In 80 
addition, the relationship between cerebral artery aneurysms and MFS has been 81 
questioned (10, 48, 49). Therefore, the current evidence does not conclusively support 82 
a link between MFS and neurovascular disorders. Advances in pharmacological and 83 
mainly surgical therapies have resulted in longer life expectancy for Marfan patients 84 
(39). However, one consequence of this undoubted improvement could be that Marfan 85 
patients are increasingly exposed to other complications, such as those of a 86 
neurovascular type. To understand the pathophysiological basis of MFS alterations, a 87 
variety of murine experimental models have been developed. The most commonly 88 
used is mice heterozygous for the Fbn1 allele encoding a missense mutation 89 
(Fbn1C1039G/+), which is representative of the most common class of mutation observed 90 
in Marfan patients. Marfan mice show impairments in aortic functional and mechanical 91 
properties that could contribute to the risk of aortic aneurysm formation (7, 8, 9). 92 
However, very little is known about the pathophysiology of small vessels in MFS. To 93 
our knowledge, only mesenteric resistance artery properties have been thoroughly 94 
analyzed, with reports of Marfan-associated increases in wall stiffness and vasomotor 95 
dysfunction (45, 46).  96 
Fibrillin-1 form microfibrils, which are a reservoir of transforming growth factor-β (TGF-97 
β) and thus contribute to different aspects of Marfan-related vascular pathophysiology 98 
(12, 19, 33). It is well-known that overexpression of TGF-β1 in the brain of non-Marfan 99 
animals contributes to cerebrovascular dysfunction (47). On the other hand, vascular 100 
NADPH oxidase is a critical source of oxidative stress (20). In this respect, NADPH 101 
oxidase 4 (Nox4) is the only family member expressed in the vascular wall (20) whose 102 
expression is regulated by TGF-β (6, 13, 22, 38). Nox4 generates H2O2 as a reactive 103 
oxygen species (ROS), and previous studies have suggested that H2O2 regulates 104 
arterial structure and function (44). Therefore, we hypothesized that Nox4 could be a 105 
relevant downstream effector of TGF-β in the cerebral vasculature in MFS. This 106 
hypothesis is based on experimental evidence that shows augmented oxidative stress 107 
in aortic and mesenteric artery dysfunction in MFS (46, 50), greater oxidative stress 108 
and Nox4 expression in cerebral than in systemic arteries (32), and the relevance of 109 
Nox4 as a source of oxidative stress in ischemic stroke (40). 110 
Although vascular alterations in systemic arteries have been previously identified in a 111 
mouse model of MFS (7, 8, 9, 45, 46, 50), cerebral artery properties have not been 112 
investigated. If cerebrovascular abnormalities were present, they might contribute to 113 
susceptibility to the development of neurovascular complications. We therefore 114 
examined middle cerebral artery (MCA) properties during MFS progression, and 115 
subsequently the putative role of Nox4 in the potential alterations that have been 116 
observed.   117 
 118 
MATERIALS AND METHODS 119 
Animals  120 
Three-, six- and nine-month-old male and female mice were similarly distributed across 121 
wild-type (n = 26) and Fbn1C1039G/+ (Marfan; n = 25) groups. Marfan mice began with 122 
matrices from the Jackson Laboratory (Charles River, Lyon, France). Moreover, 6-123 
month-old wild-type Nox4-/- (n = 7) and Marfan Nox4-/- (n = 5) mice were used. To 124 
establish the Marfan Nox4-/- mice colony, initially wild-type Nox4-/- female mice (42) 125 
were bred with Fbn1C1039G/+ (Marfan Nox4+/+) male mice. From the resulting Nox4 126 
heterozygous generation (Nox4+/-), Marfan male mice were crossed with wild-type 127 
female mice to obtain Marfan Nox4-/- male mice that were selected and successively 128 
bred with wild-type Nox4-/- female mice. All mice were housed according to institutional 129 
guidelines (constant room temperature at 22 °C, 12 h light/dark cycle, 60% humidity, 130 
and water ad libitum). All of the experiments were performed under the guidelines 131 
established by Spanish legislation (RD 1201/2005) and according to the Guide for the 132 
Care and Use of Laboratory Animals, published by the United States National Institutes 133 
of Health (NIH Publications 85-23, revised 1996). Experiments were approved by the 134 
Ethics Committee of the Universitat de Barcelona, and were carried out in compliance 135 
with European legislation.  136 
 137 
Tissue preparation 138 
MCA from the right and left hemisphere was dissected under a surgical microscope 139 
and kept in ice-cold Krebs-Henseleit solution (KHS, composition in mM: NaCl 112.0; 140 
KCl 4.7; CaCl2 2.5; KH2PO4 1.1; MgSO4 1.2; NaHCO3 25.0; and glucose 11.1) gassed 141 
with 95% O2 and 5% CO2. The proximal segment of the MCA was immediately used for 142 
pressure myography, and at the end of the assay it was handled for nuclei distribution 143 
microscopic fluorescence studies (36) and picrosirius red staining (16). Distal MCA 144 
segments were used for immunofluorescence (36) and evaluation of superoxide anion 145 
production (36). Branches of the MCA and the remaining cerebral arteries were 146 
processed for analysis of mRNA levels (36).  147 
 148 
Pressure myography 149 
Structural, mechanical and myogenic properties of the MCA were studied with a 150 
pressure myograph (Danish Myo Tech, model P100; J.P. Trading, Aarhus, Denmark), 151 
as described (16, 36). Briefly, vessels were placed on two glass microcannulas and 152 
carefully adjusted so that the vessel walls were parallel without stretching them. 153 
Intraluminal pressure was then raised to 140 mmHg, and the artery was unbuckled by 154 
adjusting the cannulas. Afterwards, the artery was left to equilibrate for 45 min at 40 155 
mmHg in gassed KHS (37°C). Intraluminal pressure was reduced to 3 mmHg, and a 156 
pressure–diameter curve (3-120 mmHg) was obtained. Internal and external diameters 157 
(DiCa and DeCa) were measured for 3 min at each intraluminal pressure. The artery was 158 
left to equilibrate for 30 min at 40 mmHg in gassed, calcium-free KHS (37°C; 0 Ca2+: 159 
omitting calcium and adding 10 mM EGTA; Sigma-Aldrich, St Louis, MO) and a second 160 
pressure-diameter curve (3-120 mmHg) was obtained in passive conditions. Structural, 161 
mechanical and myogenic parameters were analyzed as described (16).  162 
 163 
Nuclei distribution by confocal microscopy 164 
Pressured (40 mmHg)-fixed intact MCA was stained with Hoechst 33342 nuclear dye 165 
(10 μg/ml; Sigma-Aldrich) for 30 min (16, 36). Once washing had been completed, 166 
arteries were mounted on slides with a well that was made from silicon spacers, to 167 
avoid artery deformation. The slides were visualized with a Leica TCS SP2 168 
(Heidelberg, Germany) confocal system. Stacks of serial optical slices (0.4 μm thick) 169 
were captured from the adventitia to the lumen of each artery. The different MCA layers 170 
stained with Hoechst 33342 were clearly distinguished with confocal microscopy, 171 
according to the shape and/or orientation of the cell nuclei (1). At least two stacks of 172 
images of several regions were captured in each arterial segment. MetaMorph Image 173 
Analysis software (Molecular Devices, Sunnyvale, CA) was used for quantification, as 174 
reported (16).  175 
 176 
Elastin determination 177 
Total elastin content was studied in MCA cross-sections (14 µm thick) on the basis of 178 
the autofluorescent properties of elastin, as described (35). The fluorescence intensity 179 
value was used as an estimate of elastin concentration, following the assumption that 180 
the concentration of elastin has a linear relationship with fluorescence intensity (3). 181 
Preparations were viewed using a laser scanning confocal microscope (Leica TCS 182 
SP2). All the images were taken under identical conditions of zoom (×1), laser 183 
intensity, brightness, and contrast. Quantitative analysis of elastin autofluorescence 184 
was performed with MetaMorph Image Analysis software (Molecular Devices). The 185 
fluorescence signal per area was measured in at least two rings from each animal, and 186 
the results were expressed as arbitrary units. 187 
The content of elastic fibers in the internal elastic lamina (IEL) was studied in intact 188 
pressure (40 mmHg)-fixed MCA using a Leica TCS SP5 confocal microscope. Stacks 189 
of serial optical sections (0.3 μm thick) were captured from each artery. At least, two 190 
stacks of images of several regions were captured in each arterial segment. All the 191 
images were taken under identical conditions of zoom (×5), laser intensity, brightness, 192 
and contrast. Quantitative analysis was performed with MetaMorph Image Analysis 193 
software (Molecular Devices), as described (24).  194 
 195 
Collagen determination by picrosirius red staining 196 
MCA sections (14 µm thick) were stained with picrosirius red to determine total 197 
collagen (16). Images were taken using a Leica Leitz DMRB microscope equipped with 198 
a Leica DC500 camera, and analyzed with MetaMorph Image Analysis software 199 
(Molecular Devices). Total collagen content was calculated as a percentage of the 200 
stained area of each image obtained under visible light in at least two rings from each 201 
animal, and the results were expressed as arbitrary units.  202 
 203 
Immunofluorescence 204 
Frozen transverse sections (14 μm thick) of MCA were incubated (1 h) with a goat 205 
polyclonal antibody against matrix metalloproteinase (MMP)-9 (1:100; R&D Systems, 206 
Inc., Minneapolis, MN). After being washed, sections were incubated (45 min) with the 207 
secondary antibody (1:200), a donkey anti-goat IgG conjugated to Cyanine 3 (Jackson 208 
ImmunoResearch Laboratories, West Grove, PA) at 37°C. The specificity of the 209 
immunostaining was verified by omission of the primary antibody, which abolished the 210 
fluorescence signal. Quantitative analysis of fluorescence was performed with 211 
MetaMorph Image Analysis software (Molecular Devices) and the results were 212 
expressed as arbitrary units (36). 213 
 214 
Measurement of superoxide anion formation  215 
The oxidative fluorescent dye dihydroethidium (DHE) was used to evaluate production 216 
of superoxide anion in situ (14-µm thick sections) (18). Quantitative analysis of DHE-217 
derived fluorescence was performed with MetaMorph Image Analysis software 218 
(Molecular Devices), as reported (16, 36). 219 
 220 
Quantitative real-time PCR (qRT-PCR)  221 
mRNA expression was quantified by Sybr green-based quantitative real time-PCR as 222 
described (34). The expression of mRNA for GAPDH of 18S ribosomal RNA was used 223 
as an internal control. qRT-PCR reactions were set up following the manufacturer’s 224 
guidelines. Ct values obtained for each gene were referenced to GAPDH 18S (ΔΔCt) 225 
and converted to the linear form using the term 2-ΔΔCt as a value directly proportional to 226 
the copy number of cDNA and the initial quantity of mRNA (34). 227 
 228 
Statistics 229 
Results are expressed as means ± SE of the number (n) of mice indicated in the 230 
legends for Figs. 1-6. The difference between wild-type or Marfan mice and the effect 231 
of Nox4 deletion was assessed by a two-way ANOVA with Tukey’s post-test to 232 
compare groups. Data analysis was carried out using GraphPad Prism version 6 233 
software. A value of P < 0.05 was considered significant. 234 
 235 
RESULTS 236 
Structural, mechanical and myogenic properties of MCA during MFS progression   237 
To obtain MCA structural parameters, external and internal diameters were measured 238 
under fully relaxed conditions (0 Ca2+-KHS). We did not find a significant difference in 239 
external (3 months; wild-type: 167.33 ± 3.41 μm, n = 9; Marfan: 169.86 ± 4.23 μm, n = 240 
7; 6 months; wild-type: 171.00 ± 5.03 μm, n = 10; Marfan: 167.18 ± 3.79 μm, n = 11; 9 241 
months; wild-type: 168.71 ± 6.09 μm, n = 7; Marfan: 163.14 ± 2.78 μm, n = 7; 60 242 
mmHg) or internal (3 months; wild-type: 143.00 ± 2.46 μm, n = 9; Marfan: 145.00 ± 243 
4.53 μm, n = 7; 6 months; wild-type: 146.60 ± 5.20 μm, n = 10; Marfan: 141.00 ± 3.25 244 
μm, n = 11; 9 months; wild-type: 143.43 ± 6.36 μm, n = 7; Marfan: 136.00 ± 2.64 μm, n 245 
= 7; 60 mmHg) diameter in wild-type versus Marfan mice in any age group under study. 246 
At 3 months, structural parameters were similar in vessels from control and Marfan 247 
mice. However, at 6 months of age, unlike cross-sectional area (Fig. 1A) and wall 248 
thickness (results not shown), the wall/lumen (Fig. 1B) was higher (P < 0.05) in Marfan 249 
than in wild-type mice, difference that disappeared at 9 months of age. Additionally, 250 
neither the cross-sectional area (Fig. 1A) nor the wall thickness (results not shown) 251 
was modified in Marfan mice at this age. 252 
Wall stiffness is a mechanical parameter that can be determined from the stress-strain 253 
relationship (2). Since the stress-strain curve is not linear, it is more appropriate to 254 
obtain the slope of the curve (β-value). At all mice ages studied, the stress-strain 255 
relationship and the β-values were similar, which indicates that MCA stiffness is not 256 
altered in Marfan mice (Fig. 2A). 257 
We did not find a significant difference in internal diameter in active conditions in wild-258 
type versus Marfan mice in any age group under study (3 months; wild-type: 131.11 ± 259 
3.41 μm, n = 9; Marfan: 135.14 ± 3.94 μm, n = 7; 6 months; wild-type: 121.00 ± 8.40 260 
μm, n = 9; Marfan: 121.70 ± 3.93 μm, n = 10; 9 months; wild-type: 124.86 ± 5.11 μm, n 261 
= 7; Marfan: 116.57 ± 4.98 μm, n = 7; 60 mmHg). The analysis of myogenic response 262 
as a function of pressure obtained from internal diameter reductions in active relative to 263 
passive (0 Ca2+-KHS) conditions revealed that arteries from 3-month-old wild-type mice 264 
had less (P < 0.05) myogenic tone than arteries of mice from 6 and 9 months (Fig. 2B). 265 
However, neither the analysis of myogenic response as a function of pressure (Fig. 2B) 266 
nor the slope of these curves (myogenic reactivity; Table 1) showed significant 267 
differences between wild-type and Marfan MCA in all age groups.  268 
 269 
ROS production in cerebral arteries of Marfan mice and the impact of Nox4 270 
deletion  271 
We next measured expression levels of the most relevant NADPH oxidases of brain 272 
vasculature, as well as ROS production in cerebral arteries from wild-type and Marfan 273 
mice (Fig. 3). We evaluated mRNA levels of NADPH oxidase (a major source of 274 
vascular superoxide anion) catalytic (Nox1, Nox2, Nox4) and regulatory (p22phox) 275 
subunits. Marfan cerebral arteries did not show differences in Nox1 and p22phox mRNA 276 
expression levels compared with wild-type mice (Fig. 3A). In contrast, mRNA levels of 277 
Nox4 were significantly higher (P < 0.05) in Marfan mice (Fig. 3A).  278 
To understand the physiological meaning of increased Nox4 expression in MCA of 279 
Marfan mice, we generated a Marfan mice model, which was deleted for Nox4 (Nox4-/-280 
). Taking into account the aforementioned results, we chose animals at six months, in 281 
which the most significant vascular changes were observed. Absence of Nox4 282 
expression per se did not alter either Nox1 or p22phox mRNA levels (Fig. 3A). However, 283 
Nox4 deficiency in Marfan mice led to higher (P < 0.05) Nox1 mRNA expression levels 284 
than in wild-type mice (Fig. 3A). Unfortunately, Nox2 mRNA levels were undetectable. 285 
We also analyzed mRNA levels of Poldip2, which binds to p22phox and enhances Nox4 286 
activity (30), and no differences were observed (results not shown). ROS levels were 287 
evaluated by DHE-derived fluorescence, and they were higher along the MCA wall of 288 
Marfan (two-way ANOVA; P < 0.01) mice than in wild-type mice (Fig. 3B). However, 289 
post-test analysis showed significant increases (P < 0.05) in Marfan compared to wild-290 
type mice, but not between Marfan Nox4+/+ and Marfan Nox4-/-. This suggests that the 291 
superoxide anion is not increased via Nox4, but probably through other Nox such as 292 
Nox1.  293 
 294 
TGF-β production in cerebral arteries of Marfan mice and the impact of Nox4 295 
deletion  296 
We evaluated TGF-β expression in cerebral arteries from wild-type and Marfan mice in 297 
the presence and absence of Nox4. Quantitative analysis of TGF-β mRNA levels 298 
showed higher (P < 0.05) mRNA expression in Marfan than in wild-type mice (Fig. 4). 299 
However, Nox4 deletion attenuated (P < 0.001) TGF-β mRNA expression levels. These 300 
results suggest that increases in local TGF-β expression might contribute to 301 
augmenting Nox4 expression in the MCA of Marfan mice in a feed-forward fashion.  302 
 303 
Structural, mechanical and myogenic properties of MCA after Nox4 deletion   304 
We next studied the contribution of Nox4 to the MCA properties of wild-type and 305 
Marfan mice (Fig. 5). External (wild-type: 170.40 ± 5.36 μm, n = 5; Marfan: 169.33 ± 306 
5.52 μm, n = 6; wild-type Nox4-/-: 159.80 ± 4.64 μm, n = 5; Marfan Nox4-/-: 178.00 ± 307 
4.35 μm, n = 5; 60 mmHg) and internal (wild-type: 146.20 ± 4.74 μm, n = 5; Marfan: 308 
142.17 ± 5.12 μm, n = 6; wild-type Nox4-/-: 134.60 ± 5.14 μm, n = 5; Marfan Nox4-/-: 309 
142.80 ± 6.41 μm, n = 5; 60 mmHg) diameters under 0 Ca2+-KHS did not differ in wild-310 
type Nox4-/- compared with wild-type or Marfan mice. However, external diameters in 311 
MCA from Marfan Nox4-/- were more enlarged (P < 0.01) than in wild-type Nox4-/- mice. 312 
It is important to highlight that the absence of Nox4 expression per se did not alter the 313 
MCA structure. In contrast, deletion of Nox4 in Marfan mice led to an increase (P < 314 
0.05) at high intraluminal pressures (from 60 to 120 mmHg) in cross-sectional area 315 
(Fig. 5A) and wall/lumen (Fig. 5B), but not wall thickness (results not shown). 316 
Nevertheless, Nox4 deficiency did not alter the wall stiffness (Fig. 5C), the internal 317 
diameter in active conditions (wild-type: 115.60 ± 9.93 μm, n = 5; Marfan: 113.83 ± 318 
3.10 μm, n = 6; wild-type Nox4-/-: 120.25 ± 3.90 μm, n = 4; Marfan Nox4-/-: 119.20 ± 319 
4.55 μm, n = 5; 60 mmHg), the myogenic response as a function of pressure (Fig. 5D), 320 
and the myogenic reactivity (wild-type: 0.133 ± 0.080, n = 4; Marfan: 0.077 ± 0.063, n = 321 
6; wild-type Nox4-/-: 0.033 ± 0.062, n = 4; Marfan Nox4-/-: 0.007 ± 0.030, n = 5). 322 
 323 
Distribution of nuclei through the MCA wall 324 
We next examined whether the aforementioned structural differences could be 325 
attributed to changes in the cell density of the MCA wall. To this aim, we analyzed the 326 
nuclei distribution from intact and pressurized MCA. As reported in Table 2, total wall, 327 
adventitial and media MCA volumes, as well as smooth muscle and endothelial cell 328 
number, were almost the same in Marfan and wild-type mice. However, the absence of 329 
Nox4 in Marfan mice led to an augmented wall volume (P < 0.01) and a decrease (P < 330 
0.05) in adventitial cell number. Taken together, these results suggest that the MCA 331 
structural alterations occurring in Marfan mice of 6 months of age would not implicate 332 
an increase in the number of wall cell nuclei, regardless of the presence or absence of 333 
Nox4.   334 
 335 
Elastin and collagen contents in the MCA wall  336 
Total elastin fluorescence in MCA cross sections was similar among groups (wild-type: 337 
91.8 ± 17.7, n = 6; Marfan: 66.8 ± 9.9, n = 5; wild-type Nox4-/-: 80.8 ± 15.5, n = 5; 338 
Marfan Nox4-/-: 86.8 ± 4.8, n = 4). In addition, analysis of internal elastic lamina (IEL) 339 
thickness from intact pressurized MCA showed no differences among groups (Table 2). 340 
Although values of the average fluorescence intensity per pixel indicated a similar 341 
amount of elastin in wild-type and Marfan mice, a reduction (P < 0.05) in IEL 342 
fluorescence was observed between Marfan Nox4-/- and Marfan Nox4+/+mice (Table 2). 343 
To investigate whether the observed MCA wall hypertrophy in Marfan mice could be a 344 
consequence of excess collagen deposition, we measured the expression and content 345 
of collagen and proteins involved in extracellular matrix (ECM) degradation. Neither 346 
mRNA levels of collagen 1A1 (Fig. 6A) nor collagen deposition along the MCA wall 347 
(Fig. 6B) was altered in Marfan compared with wild-type mice. However, a Marfan-348 
associated increase (P < 0.05) in matrix metalloproteinase (MMP)-9 mRNA levels was 349 
observed (Fig. 6A). Nox4-/- mice showed an intrinsic increase (P < 0.05) of MMP-9 350 
mRNA (Fig. 6A) that was accompanied by decreased (P < 0.05) collagen 1A1 mRNA 351 
levels (Fig. 6A), with unchanged collagen deposition (Fig. 6B). Importantly, Nox4 352 
deficiency in Marfan mice led to augmented (P < 0.05) collagen deposition (Fig. 6B), 353 
despite diminished (P < 0.01) collagen 1A1 and augmented (P < 0.01) MMP-9 mRNA 354 
levels (Fig. 6A). Protein expression of MMP-9, assessed by immunofluorescence, was 355 
higher (P < 0.05) in Marfan than in wild-type mice, and was attenuated (P < 0.05) by 356 
Nox4 deletion (Fig. 6C). Overall, these results suggest that collagen degradation is 357 
augmented in the MCA of Marfan mice, and that even though transcriptional negative 358 
feedback modulation is initiated, net collagen deposition seem to contribute to MCA 359 
hypertrophy in Marfan Nox4-/- mice.  360 
 361 
DISCUSSION 362 
The aim of the present study was to characterize for the first time the cerebral artery 363 
properties of a mouse heterozygous for a mutation in Fbn1 (Fbn1C1039G/+), which 364 
manifests many clinical features of MFS. We observed that cerebral arteries from 365 
Marfan mice, along the progression of the disease (evaluated by the appearance of 366 
aortic aneurysm), developed slightly increased wall/lumen, accompanied by unaltered 367 
wall stiffness and myogenic autoregulation. At the same time, it is well-known that 368 
Marfan mice show hyperactivation of TGF-β signaling (19, 33), which in turn is known 369 
that upregulates the expression of Nox4 (6, 13, 22). Consistently, MCA from Marfan 370 
mice increased TGF-β and Nox4 mRNA levels. To investigate the potential influence of 371 
the Nox4 signaling pathway in cerebral artery properties, we generated Marfan mice 372 
with abrogated Nox4 expression. Strikingly, the loss of Nox4 in Marfan mice 373 
aggravated structural alterations, which reveals a critical role for Nox4 in preventing 374 
cerebrovascular changes in MFS.   375 
Large cerebral arteries, like the MCA, contribute substantially to cerebrovascular 376 
resistance (21). In this scenario, cerebrovascular adaptations permit brain circulation to 377 
maintain cerebral blood flow and meet metabolic demands, despite cardiovascular 378 
disturbances (21, 25). In our mouse model of MFS, MCA wall/lumen was increased at 379 
6 months of age, which suggests age-related (i.e. not pre-existing) minor cerebral 380 
artery structural alterations in MFS. The increase in wall/lumen is a known adaptive 381 
process that contributes to maintaining cerebrovascular resistance and protecting 382 
downstream microcirculation from elevated arterial blood pressure, which can 383 
subsequently lead to vascular dysfunction (2). However, we did not observe significant 384 
wall/lumen differences in 9-month-old mice, most likely due to the slight age-dependent 385 
decline of this parameter in wild-type mice. Remarkably, Marfan animals did not display 386 
significant alterations in MCA wall stiffness during aging. In contrast, both aorta (8) and 387 
mesenteric arteries (46) from Marfan mice showed enhanced wall stiffness. In addition, 388 
the lack of changes in middle cerebral artery myogenic tone and reactivity suggest that 389 
myogenic autoregulatory mechanisms are preserved. Taken together, the different 390 
magnitude of changes observed during MFS progression in systemic (7, 8, 9, 45, 46, 391 
50) compared to cerebral arteries suggests region-specific differences in sensitivity to 392 
MFS, and highlights that cerebral blood flow is tightly regulated. 393 
Increased ROS production and/or oxidative stress have been found to be involved in 394 
systemic artery alterations related to MFS (46, 50). Accordingly, we observe that, MCA 395 
from Marfan mice also showed augmented ROS generation when compared to wild-396 
type. Even though ROS production is often linked to an increase in vascular collagen 397 
deposition (4), we did not detect significant collagen accumulation in MCA from 6-398 
month-old Marfan mice. ECM breakdown mediated by MMP has been associated with 399 
thoracic aortic aneurysm in MFS (8). Here, we have found augmented MMP-9 protein 400 
expression in the MCA of Marfan mice, which could explain the increase in collagen 401 
degradation. In addition, although fibrillin-1 is a scaffolding protein that is crucial for 402 
elastin assembly (41), fibrillin-1 defects in Marfan animals do not seem to be coupled 403 
with an apparent disruption of MCA wall elastin. Collectively, the absence of major 404 
Marfan-induced ECM alterations in MCA are in contrast with changes reported in aorta 405 
(8, 12, 14), but support previous findings that challenge the supposed association 406 
between MFS and cerebral artery aneurysms (10, 48, 49). Nevertheless, we have to be 407 
cautious in generalizing these results to human beings, as our study is limited to one of 408 
the various available experimental murine models of MFS, whose clinical symptoms 409 
are highly variable depending on their penetrance.  410 
Unlike wild-type mice, Marfan Nox4-/- compared with Marfan Nox4+/+ mice presented 411 
greater MCA collagen deposition, which is a sign of fibrosis and vascular damage, 412 
despite showing a transcriptional negative feedback loop involving decreased collagen 413 
1A1 and increased MMP-9. Augmentation of collagen deposition probably contributes 414 
to increased MCA cross-sectional area in Marfan Nox4-/- mice, which was not 415 
associated with alterations in wall stiffness. These data support previous findings that 416 
changes in the quantity, distribution and organization of new collagen are determinant 417 
to defining the stiffness of the arterial wall (4).  418 
Recent studies report an inverse relationship between vascular H2O2 production and 419 
collagen deposition (31, 44, 51). Nox4 is an important source of oxidative stress in 420 
cerebral arteries (32) that seems to play a pathophysiological role in the brain (40). 421 
However, unlike Nox1 and Nox2, Nox4 also exerts a protective role in the vasculature 422 
(20, 27, 42). This difference could be due to Nox4 capacity to produce H2O2, which is 423 
the main detectable ROS that is produced, rather than the superoxide anion (43). It has 424 
been suggested that Poldip2-mediated, and possibly, Nox4-derived H2O2 production 425 
could reduce aortic collagen deposition (30, 44). Consistent with this idea, studies 426 
show convincing evidence that MMP-9 activation and expression is positively 427 
modulated by H2O2 predisposing to aortic aneurysm formation (37). In our study, the 428 
presence of Nox4 was associated with increased MMP-9 protein expression in the 429 
MCA of Marfan mice. Besides, significant collagen deposition was only observed after 430 
Nox4 deletion in Marfan mice. However, based on present data we cannot confirm 431 
whether Nox4-derived H2O2 might repress MCA collagen deposition in MFS. In 432 
addition, upregulation of aortic Nox1 can promote superoxide anion production and 433 
collagen formation (15). Thus, we cannot exclude the possibility that a Nox4-dependent 434 
negative modulatory effect on Nox1-derived superoxide anion production might also 435 
contribute to mitigating collagen accumulation in the MCA of Marfan mice.  436 
Current evidence has not established a clear link between MFS and neurovascular 437 
disorders (10, 48, 49), but since life expectancy increases in MFS patients who have 438 
been diagnosed and treated, they could be exposed to more potential causes of 439 
neurovascular disorders. The present study is the first to report the development of 440 
modest but potentially relevant cerebrovascular alterations in an experimental murine 441 
model of MFS. This study also contributes to our understanding of the role of the TGF-442 
β/Nox4 signaling pathway in cerebral vasculature in healthy, and particularly in Marfan 443 
patients, since we show that genetic deletion of Nox4 in Marfan mice induces collagen 444 
deposition which contributes to arterial wall hypertrophy, thereby causing overt MCA 445 
structural alterations. In fact, previous evidence suggests a pathophysiological role of 446 
Nox4 in brain damage (40). Overall, the results of the present study suggest that Nox4 447 
has a role in regulating cerebrovascular resistance in Marfan animals. Thus, our 448 
findings lead to the hypothesis that an overall reduction in TGF-β signaling, an ongoing 449 
therapeutic approach against aortic aneurysm formation in MFS (29), might have a 450 
negative impact on brain circulation. Similarly, recent evidence supports a critical role 451 
of TGF-β signaling in maintaining postnatal aortic homeostasis (23, 28), and an early 452 
protective role of TGF-β during aortic aneurysm progression (11). However, further 453 
evidence is required to corroborate that Nox4 activation could actually play a beneficial 454 
role in the cerebral circulation of Marfan patients.  455 
 456 
ACKNOWLEDGMENTS 457 
We are grateful to Federica Dinolfo and Vanessa Hernandez for their excellent 458 
technical assistance, to Dr. Darya Gorbenko Del Blanco for helpful comments, and to 459 
the confocal microscopy core from the Universitat Autònoma de Barcelona.  460 
 461 
GRANTS 462 
The research was funded by Ministerio de Ciencia e Innovación (SAF2010-19282; 463 
SAF2014-56111-R) grants to E.V., a Generalitat de Catalunya (2014SGR574) grant to 464 
E.V. and F.J-A., and grants from the Ministerio de Ciencia e Innovación (BFU23012-465 
33932), the Fundación Ramon Areces (Areces11-07) and the Generalitat de Catalunya 466 
(2014SGR334) to G.E. G.E. also acknowledges the National Marfan Foundation for its 467 
support. Additionally, this work was supported by a Deutsche Forschungsgemeinschaft 468 
(DFG; SFB815/TP1) grant to K.S. Y.O. is a predoctoral fellow (FPU) of the Ministerio 469 
de Educación y Ciencia (Spain) and T.M. was supported by a fellowship from the 470 
National Council of Technological and Scientific Development - Science without 471 
Borders scholarship program (Brazilian Federal Government) 472 
 473 
DISCLOSURES 474 
No conflicts of interest, financial or otherwise, are declared by the author(s). 475 
 476 
REFERENCES 477 
1. Arribas SM, Hillier C, González C, McGrory S, Dominiczak AF, McGrath JC. 478 
Cellular aspects of vascular remodeling in hypertension revealed by confocal 479 
microscopy. Hypertension 30: 1455-1464, 1997. 480 
2. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic 481 
hypertension. Hypertension 13: 968-972, 1989. 482 
3. Blomfield J, Farrar JF. The fluorescent properties of maturing arterial elastin. 483 
Cardiovasc Res 3: 161-170, 1969. 484 
4. Briones AM, Arribas SM, Salaices M. Role of extracellular matrix in vascular 485 
remodeling of hypertension. Curr Opin Nephrol Hypertens 19: 187-194, 2010. 486 
5. Canadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome. Part 1: 487 
pathophysiology and diagnosis. Nat Rev Cardiol 7: 256-265, 2010.  488 
6. Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernández M, 489 
Fabregat I. Upregulation of the NADPH oxidase NOX4 by TGF-beta in 490 
hepatocytes is required for its pro-apoptotic activity. J Hepatol 49: 965-976, 491 
2008.  492 
7. Chung AW, Au Yeung K, Cortes SF, Sandor GG, Judge DP, Dietz HC, van 493 
Breemen C. Endothelial dysfunction and compromised eNOS/Akt signaling in 494 
the thoracic aorta  during the progression of Marfan syndrome. Br J Pharmacol 495 
150: 1075-1083, 2007a.  496 
8. Chung AW, Au Yeung K, Sandor GG, Judge DP, Dietz HC, van Breemen C. 497 
Loss of elastic fiber integrity and reduction of vascular smooth muscle 498 
contraction resulting from the upregulated activities of matrix metalloproteinase-499 
2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res 101: 500 
512-522, 2007b.  501 
9. Chung AW, Yang HH, van Breemen C. Imbalanced synthesis of 502 
cyclooxygenase-derived thromboxane A2 and prostacyclin compromises 503 
vasomotor function of the thoracic aorta in Marfan syndrome. Br J Pharmacol 504 
152: 305-312, 2007c.  505 
10. Conway JE, Hutchins GM, Tamargo RJ. Marfan syndrome is not asso- ciated 506 
with intracranial aneurysms. Stroke 30:1632-1636, 1999.  507 
11. Cook JR, Clayton NP, Carta L, Galatioto J, Chiu E, Smaldone S, Nelson CA, 508 
Cheng SH, Wentworth BM, Ramirez F. Dimorphic effects of transforming 509 
growth factor-β signaling during aortic aneurysm progression in mice suggest a 510 
combinatorial therapy for Marfan syndrome. Arterioscler Thromb Vasc Biol 35: 511 
911-917, 2015. 512 
12. Crosas-Molist E, Meirelles T, López-Luque J, Serra-Peinado C, Selva J, Caja L, 513 
Del Blanco DG, Uriarte JJ, Bertran E, Mendizábal Y, Hernández V, García-514 
Calero C, Busnadiego O, Condom E, Toral D, Castellà M, Forteza A, Navajas 515 
D, Sarri E, Rodríguez-Pascual F, Dietz HD, Fabregat I, Egea G. Vascular 516 
Smooth Muscle Cell Phenotypic Changes in Patients With Marfan Syndrome. 517 
Arterioscler Thromb Vasc Biol 35: 960-972, 2015. 518 
13. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu 519 
D. NADPH oxidase 4 mediates transforming growth factor-beta1-induced 520 
differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97: 900-907, 521 
2005.  522 
14. Cui JZ, Tehrani AY, Jett KA, Bernatchez P, van Breemen C, Esfandiarei M. 523 
Quantification of aortic and cutaneous elastin and collagen morphology in 524 
Marfan syndrome by multiphoton microscopy. J Struct Biol 187: 242-253, 2014. 525 
15. Dammanahalli JK, Wang X, Sun Z. Genetic interleukin-10 deficiency causes 526 
vascular remodeling via the upregulation of Nox1. J Hypertens 29: 2116-2125, 527 
2011.  528 
16. Dantas AP, Onetti Y, Oliveira MA, Carvalho MH, Heras M, Vila E, Jiménez-529 
Altayó F. Western diet consumption promotes vascular remodeling in non-530 
senescent mice consistent with accelerated senescence, but does not modify 531 
vascular morphology in senescent ones. Exp Gerontol 55: 1-11, 2014.  532 
17. Dietz HC, Cutting CR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, 533 
Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Stetten G, 534 
Meyers DA, Francomano CA. Marfan syndrome caused by a recurrent de novo 535 
missense mutation in the fibrillin gene. Nature 352: 337-339, 1991. 536 
18. Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen 537 
species in cardiovascular studies. Hypertension 49: 717-727, 2007. 538 
19. Doyle JJ, Gerber EE, Dietz HC. Matrix-dependent perturbation of TGFβ 539 
signaling and disease. FEBS Lett 586: 2003-2015, 2012. 540 
20. Drummond GR, Sobey CG. Endothelial NADPH oxidases: which NOX to target 541 
in vascular disease? Trends Endocrinol Metab 25:452-463, 2014.  542 
21. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral 543 
microvascular pressure. Circ Res 66: 8-17, 1990. 544 
22. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur 545 
S, Martinez FJ, Thannickal VJ. NADPH oxidase-4 mediates myofibroblast 546 
activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081, 547 
2009.  548 
23. Hu JH, Wei H, Jaffe M, Airhart N, Du L, Angelov SN, Yan J, Allen JK, Kang I, 549 
Wight TN, Fox K, Smith A, Enstrom R, Dichek DA. Postnatal Deletion of the 550 
Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells 551 
Causes Severe Aortopathy in Mice. Arterioscler Thromb Vasc Biol 35: 2647-552 
2656, 2015. 553 
24. Jiménez-Altayó F, Martín A, Rojas S, Justicia C, Briones AM, Giraldo J, Planas 554 
AM, Vila E. Transient middle cerebral artery occlusion causes different 555 
structural, mechanical, and myogenic alterations in normotensive and 556 
hypertensive rats. Am J Physiol Heart Circ Physiol 293: H628-H635, 2007.  557 
25. Johnson AC, Cipolla MJ. The cerebral circulation during pregnancy: adapting to 558 
preserve normalcy. Physiology (Bethesda) 30: 139-147, 2015. 559 
26. Judge DP, Dietz HC. Marfan's syndrome. Lancet 366: 1965-1976, 2005. 560 
27. Konior A, Schramm A, Czesnikiewicz-Guzik M, Guzik TJ. NADPH oxidases in 561 
vascular pathology. Antioxid Redox Signal 20: 2794-2814, 2014. 562 
28. Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, Ferruzzi J, Kim RW, Geirsson A, Dietz 563 
HC, Offermanns S, Humphrey JD, Tellides G. Tgfbr2 disruption in postnatal 564 
smooth muscle impairs aortic wall homeostasis. J Clin Invest 124: 755-767, 565 
2014. 566 
29. Loeys BL. Angiotensin receptor blockers: a panacea for Marfan syndrome and 567 
related disorders? Drug Discov Today. 20: 262-266, 2015. 568 
30. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, 569 
Papaharalambus C, Lassègue B, Griendling KK. Poldip2, a novel regulator of 570 
Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105: 571 
249-259, 2009. 572 
31. Maiellaro-Rafferty K, Weiss D, Joseph G, Wan W, Gleason RL, Taylor WR. 573 
Catalase overexpression in aortic smooth muscle prevents pathological 574 
mechanical changes underlying abdominal aortic aneurysm formation. Am J 575 
Physiol Heart Circ Physiol 301: H355-H362, 2011. 576 
32. Miller AA, Drummond GR, Schmidt HH, Sobey CG. NADPH oxidase activity and 577 
function are profoundly greater in cerebral versus systemic arteries. Circ Res 578 
97: 1055-1062, 2005. 579 
33. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, 580 
Ramirez F, Sakai LY, Dietz HC. Dysregulation of TGF-beta activation 581 
contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407-411, 2003. 582 
34. Novensa L, Selent J, Pastor M, Sandberg K, Heras M, Dantas AP. Equine 583 
estrogens impair nitric oxide production and endothelial nitric oxide synthase 584 
transcription in human endothelial cells compared with the natural 17{beta}-585 
estradiol. Hypertension 56: 405-411, 2010. 586 
35. Ogalla E, Claro C, Alvarez de Sotomayor M, Herrera MD, Rodriguez-Rodriguez 587 
R. Structural, mechanical and myogenic properties of small mesenteric arteries 588 
from ApoE KO mice: characterization and effects of virgin olive oil diets. 589 
Atherosclerosis 238: 55-63, 2015.  590 
36. Onetti Y, Dantas AP, Pérez B, Cugota R, Chamorro A, Planas AM, Vila E, 591 
Jiménez-Altayó F. Middle cerebral artery remodeling following transient brain 592 
ischemia is linked to early postischemic hyperemia: a target of uric acid 593 
treatment. Am J Physiol Heart Circ Physiol 308: H862-H874, 2015.  594 
37. Parastatidis I, Weiss D, Joseph G, Taylor WR. Overexpression of catalase in 595 
vascular smooth muscle cells prevents the formation of abdominal aortic 596 
aneurysms. Arterioscler Thromb Vasc Biol 33: 2389-2396, 2013. 597 
38. Peshavariya HM, Chan EC, Liu GS, Jiang F, Dusting GJ. Transforming growth 598 
factor-β1 requires NADPH oxidase 4 for angiogenesis in vitro and in vivo. J Cell 599 
Mol Med 18: 1172-1183, 2014.  600 
39. Pyeritz RE, Loeys B. The 8th international research symposium on the Marfan 601 
syndrome and related conditions. Am J Med Genet A 158: 42-49, 2012. 602 
40. Radermacher KA, Wingler K, Langhauser F, Altenhöfer S, Kleikers P, Hermans 603 
JJ, Hrabě de Angelis M, Kleinschnitz C, Schmidt HH. Neuroprotection after 604 
stroke by targeting NOX4 as a source of oxidative stress. Antioxid Redox Signal 605 
18: 1418-1427, 2013. 606 
41. Reinhardt DP, Chalberg SC, Sakai LY. The structure and function of fibrillin. 607 
Ciba Found Symp 192: 128-143, 1995. 608 
42. Schroder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, 609 
Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, and Brandes 610 
RP. Nox4 is a protective reactive oxygen species generating vascular NADPH 611 
oxidase. Circ Res 110: 1217-1225, 2012. 612 
43. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, 613 
Fórró L, Schlegel W, Krause KH. NOX4 activity is determined by mRNA levels 614 
and reveals a unique pattern of ROS generation. Biochem J 406: 105-114, 615 
2007. 616 
44. Sutliff RL, Hilenski LL, Amanso AM, Parastatidis I, Dikalova AE, Hansen L, 617 
Datla SR, Long JS, El-Ali AM, Joseph G, Gleason RL Jr, Taylor WR, Hart CM, 618 
Griendling KK, Lassègue B. Polymerase delta interacting protein 2 sustains 619 
vascular structure and function. Arterioscler Thromb Vasc Biol 33: 2154-2161, 620 
2013. 621 
45. Syyong HT, Chung AW, van Breemen C. Marfan syndrome decreases Ca2+ 622 
wave frequency and vasoconstriction in murine mesenteric resistance arteries 623 
without changing underlying mechanisms. J Vasc Res 48: 150-162, 2011.  624 
46. Syyong HT, Chung AW, Yang HH, van Breemen C. Dysfunction of endothelial 625 
and smooth muscle cells in small arteries of a mouse model of Marfan 626 
syndrome. Br J Pharmacol 158: 1597-1608, 2009.  627 
47. Tong XK, Nicolakakis N, Kocharyan A, Hamel E. Vascular remodeling versus 628 
amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions 629 
associated with Alzheimer's disease. J Neurosci 25: 11165-11174, 2005. 630 
48. van den Berg JS, Limburg M, Hennekam RC. Is Marfan syndrome associated 631 
with symptomatic intracranial aneurysms? Stroke 27:10-12, 1996.  632 
49. Wityk RJ, Zanferrari C, Oppenheimer S. Neurovascular complications of marfan 633 
syndrome: a retrospective, hospital-based study. Stroke 33: 680-684, 2002. 634 
50. Yang HH, van Breemen C, Chung AW. Vasomotor dysfunction in the thoracic 635 
aorta of Marfan syndrome is associated with accumulation of oxidative stress. 636 
Vascul Pharmacol 52: 37-45, 2010.  637 
51. Zhou RH, Vendrov AE, Tchivilev I, Niu XL, Molnar KC, Rojas M, Carter JD, 638 
Tong H, Stouffer GA, Madamanchi NR, Runge MS. Mitochondrial oxidative 639 
stress in aortic stiffening with age: the role of smooth muscle cell function. 640 
Arterioscler Thromb Vasc Biol 32: 745-755, 2012. 641 
 642 
 643 
FIGURE CAPTIONS 644 
Fig. 1. Structural properties of middle cerebral arteries in 3-, 6- and 9-month-old wild-645 
type and Marfan mice. (A) Cross-sectional area (CSA)-intraluminal pressure in passive 646 
conditions (0 Ca2+-KHS) and (B) wall/lumen-intraluminal pressure. Results are the 647 
means ± SE from wild-type (3 months: n = 9; 6 months: n = 9; 9 months: n = 7) and 648 
Marfan (3 months: n = 7; 6 months: n = 11; 9 months: n = 7) mice. *P < 0.05 by two-649 
way ANOVA. 650 
Fig. 2. Mechanical and myogenic properties of middle cerebral arteries in 3-, 6-, 9-651 
month-old wild-type and Marfan mice. (A) Stress-Strain (Di/Do). (B) Internal diameter in 652 
active (2.5 mM Ca2+-KHS; DiCa) relative to passive (Di0Ca) conditions. Do, internal 653 
diameter at 3 mmHg; Di, observed internal diameter from a given intravascular 654 
pressure. Results are the means ± SE from wild-type (3 months: n = 9; 6 months: n = 655 
7-8; 9 months: n = 7) and Marfan (3 months: n = 7; 6 months: n = 7-11; 9 months: n = 656 
6-7) mice.  657 
Fig. 3. Influence of Nox4 deletion (Nox4-/-) on reactive oxygen species production of 658 
middle cerebral arteries in 6-month-old wild-type and Marfan mice. (A) Comparative 659 
analysis of cerebral artery mRNA levels of the NADPH oxidase subunit Nox1, Nox4 660 
and p22phox. mRNA levels are expressed as 2−ΔΔCt using 18S as internal control. (B) 661 
Representative photomicrographs and quantitative analysis of fluorescence intensity of 662 
confocal microscopic middle cerebral artery sections labelled with the oxidative dye 663 
dihydroethidium (DHE), which produces a red fluorescence when oxidized by 664 
superoxide anion. END, endothelium; SM, smooth muscle; ADV, adventitia. Results 665 
are the means ± SE from wild-type (n = 5), Marfan (n = 5), wild-type Nox4-/- (n = 5-7) 666 
and Marfan Nox4-/- (n = 5) mice. *P < 0.05, **P < 0.01, ***P < 0.001 by two-way 667 
ANOVA with Tukey’s post-test. All experimental groups were compared against each 668 
other but only significant comparisons are indicated. 669 
Fig. 4. Influence of Nox4 deletion (Nox4-/-) on transforming growth factor (TGF)-β 670 
mRNA levels of cerebral arteries in 6-month-old wild-type and Marfan mice. mRNA 671 
levels are expressed as 2−ΔΔCt using 18S as internal control. Results are the means ± 672 
SE from wild-type (n = 5), Marfan (n = 5), wild-type Nox4-/- (n = 7) and Marfan Nox4-/- (n 673 
= 5) mice. *P < 0.05, ***P < 0.001 by two-way ANOVA with Tukey’s post-test. All 674 
experimental groups were compared against each other but only significant 675 
comparisons are indicated. 676 
Fig. 5. Influence of Nox4 deletion (Nox4-/-) on structural, mechanical and myogenic 677 
properties of middle cerebral arteries in 6-month-old wild-type and Marfan mice. (A) 678 
Cross-sectional area (CSA)-intraluminal pressure in passive conditions (0 Ca2+-KHS). 679 
(B) wall/lumen-intraluminal pressure. (C) Stress-Strain (Di/Do). (D) Internal diameter in 680 
active (2.5 mM Ca2+-KHS; DiCa) relative to passive (Di0Ca) conditions. Do, internal 681 
diameter at 3 mmHg; Di, observed internal diameter from a given intravascular 682 
pressure. Results are the means ± SE from wild-type (n = 5), Marfan (n = 6), wild-type 683 
Nox4-/- (n = 5) and Marfan Nox4-/- (n = 5) mice. *P < 0.05 by two-way ANOVA. All 684 
experimental groups were compared against each other but only significant 685 
comparisons are indicated. 686 
Fig. 6. Influence of Nox4 deletion (Nox4-/-) on collagen expression and homeostasis of 687 
middle cerebral arteries in 6-month-old wild-type and Marfan mice. (A) Comparative 688 
analysis of cerebral artery mRNA levels of collagen 1A1 (Col1A1) and matrix 689 
metalloproteinase (MMP)-9. mRNA levels are expressed as 2−ΔΔCt using 18S as internal 690 
control. (B) Representative photomicrographs and quantitative analysis of total middle 691 
cerebral artery collagen staining using picrosirius red. (C) Representative 692 
photomicrographs and quantification of MMP-9 immunofluorescence of confocal 693 
microscopic middle cerebral artery sections. Results are the means ± SE from wild-694 
type (n = 5-7), Marfan (n = 5), wild-type Nox4-/- (n = 4-5) and Marfan Nox4-/- (n = 5) 695 
mice. *P < 0.05; **P < 0.01 by two-way ANOVA with Tukey’s post-test. All experimental 696 
groups were compared against each other but only significant comparisons are 697 
indicated. 698 
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Table 1 Slope value (myogenic reactivity) of the myogenic response as a function of 
pressure curve in middle cerebral arteries from 3-, 6- and 9-month-old wild-type and Marfan 
mice.  
 
 
 
 
 
 
 
 
 
Results are the means ± SE from wild-type (3 months: n = 9; 6 months: n = 7; 9 months: n = 
7) and Marfan (3 months: n = 7; 6 months: n = 7; 9 months: n = 7) mice. 
 wild-type Marfan 
Age (months)   
3 0.062 ± 0.033 0.043 ± 0.033 
6 0.095 ± 0.038 0.108 ± 0.061 
9 0.104 ± 0.049 0.064 ± 0.027 
1 
 
Table 2 Comparison of nuclei distribution and internal elastic lamina elastin content in 
pressurized segments of middle cerebral arteries from 6-month-old wild-type and Marfan 
mice in the presence and absence of Nox4. 
 Nox4+/+ Nox4−/− 
 wild-type Marfan wild-type Marfan 
Wall volume 
(mm3) 
 0.006 ± 
0.0004 
0.007 ± 
0.0002 
0.006 ± 
0.0002 
0.008 ± 
0.0008** 
Adventitial 
volume 
(mm3) 
0.004 ± 
0.0004 
0.004 ± 
0.0008 
0.004 ± 
0.0005 
0.004 ± 
0.0015 
Media volume 
(mm3) 
0.002 ± 
0.0007 
0.002 ± 
0.0006 
0.002 ± 
0.0006 
0.002 ± 
0.0007 
Number of 
AC/mm3  144 ± 105 399 ± 96 158 ± 102 34 ± 21* 
Number of 
SMC/mm3  1279 ± 129 1131 ± 118 1115 ± 177 1302 ± 232 
Total number of 
EC  781 ± 71 553 ± 133 745 ± 138 897 ± 66 
IEL thickness 
(μm)  2.9 ± 0.4 3.0 ± 0.4 3.4 ± 0.6 2.6 ± 0.2 
IEL fluorescence 
intensity  
(average pixel) 
 23.6 ± 6.5 28.6 ± 3.8 22.3 ± 3.5 13.5 ± 2.0* 
 
AC, adventitial cells; SMC, smooth muscle cells; EC, endothelial cells; IEL, internal elastic 
lamina. Results are the means ± SE from wild-type (n = 5), Marfan (n = 5), wild-type Nox4−/− 
(n = 5) and Marfan Nox4−/− (n = 5) mice. * P < 0.05, ** P < 0.01, Marfan vs. Marfan Nox4−/− by 
two-way ANOVA with Tukey's post-test. 
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